Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel
OTCMKTS:TRUMY

Terumo Q1 2026 Earnings Report

Terumo logo
$14.59 +0.26 (+1.81%)
As of 03:59 PM Eastern
ProfileEarnings HistoryForecast

Terumo EPS Results

Actual EPS
$0.20
Consensus EPS
$0.17
Beat/Miss
Beat by +$0.03
One Year Ago EPS
N/A

Terumo Revenue Results

Actual Revenue
$1.76 billion
Expected Revenue
$1.80 billion
Beat/Miss
Missed by -$32.81 million
YoY Revenue Growth
N/A

Terumo Announcement Details

Quarter
Q1 2026
Date
8/7/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Terumo's next earnings date is estimated for Wednesday, November 11, 2026, based on past reporting schedules.

Conference Call Resources

Terumo Earnings Headlines

Terumo ADR (TRUMY)
September 5, 2026  |  es.investing.comhttps://es.investing.com/equities/terumo-adr
Terumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks Transcript
August 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4935290-terumo-corporation-trumy-q1-2027-earnings-call-prepared-remarks-transcript
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
September 11 at 1:00 AM  |  Porter & Company (Ad)
Terumo Corporation (TRUMY) Analyst/Investor Day Transcript
June 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4914117-terumo-corporation-trumy-analyst-investor-day-transcript
Terumo ADR Stock Price History
May 17, 2026  |  investing.comhttps://www.investing.com/equities/terumo-adr-historical-data
Terumo Corporation (TRUMY) Q4 2026 Earnings Call Transcript
May 17, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4905155-terumo-corporation-trumy-q4-2026-earnings-call-transcript
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.

Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions. The company also supplies blood management products, including blood bags and automated systems, as well as hospital products such as syringes, infusion systems and injection-related devices. In addition, Terumo develops technologies for therapeutic areas including neurovascular care, aortic treatment and cell and gene therapies.

Terumo serves health care providers and patients in Japan and international markets across the Americas, Europe, Asia and other regions. Its products are marketed through a combination of direct operations, subsidiaries and distribution networks, supporting medical professionals in areas including cardiovascular care, blood management and general hospital practice.

View Terumo Profile
Earnings Tools